
Clinical Trials and a Complex Psychedelic Future w/ Dr. Alan Davis
In this Episode: Clinical research often excludes the diversity of everyday life, making real-world access to psychedelic therapy look very different than a trial setting. As Dr. Alan Davis highlights, thorough preparation and a safe, trusting therapeutic relationship are essential to preventing harm and fostering genuine healing. Key Takeaways: The Human Connection to Healing: Clinical trials often try to isolate a drug’s biological effect, but decades of psychotherapy research show that therapeutic alliance and thorough preparation are the primary drivers of positive outcomes. Clinical Trials Exclude Real-World Realities: Rigid screening criteria in research leave out the complex, diverse realities of everyday people, highlighting a need for naturalistic and community-based settings to understand how psychedelics work in practice. Internal Protection Isn’t Brokenness: Trauma-response mechanisms like dissociation or hypervigilance are protective strategies built for survival; healing requires a slow, gentle approach rather than trying to “demolish” one’s defensive structures overnight. Chapters: 00:00:00 Intro 00:08:00 Alan's Story 00:18:19 Clinical Trials 00:36:18 Dosages 00:41:39 Addiction, Safety, Healing 00:51:25 Treatment and Diversity 00:58:15 Gurus and the System 01:10:07 The Harm of Doing Good 01:25:57 Psychedelic Hopes and Dreams More From Our Guest: Follow Dr. Alan K. Davis on LinkedIn The Center for Psychology Drug Research and Education at the Ohio State University Read the companion article on our blog. This podcast is edited by Chad Eschman. Our music is by Mic Coats. Psychedelic Passage is your partner in safe, supported, and effective psychedelic journeys. As the first concierge service in the U.S., we connect you with vetted facilitators who value integrity and expertise. Start your free Match Making Process, join our Online Learning Community, and explore a range of educational articles at psychedelicpassage.com.
- Transcript